dc.creator | Javorac J., Živanovic D., Stojkov S., Milicic J.D., Fradelos E., Savic N. | en |
dc.date.accessioned | 2023-01-31T08:28:51Z | |
dc.date.available | 2023-01-31T08:28:51Z | |
dc.date.issued | 2021 | |
dc.identifier | 10.26355/eurrev_202112_27647 | |
dc.identifier.issn | 11283602 | |
dc.identifier.uri | http://hdl.handle.net/11615/74091 | |
dc.description.abstract | OBJECTIVE: COVID-19 is associated with an increased incidence of pulmonary embolism (PE). Elevated D-dimer levels are linked to an increased risk of PE and poor clinical outcome. We reported a case of PE in a COVID-19 patient with normal D-dimer levels and conducted a review of the literature on the subject. CASE REPORT: A 38-year-old man with no prior comorbidities returned to the COVID-19 outpatient clinic 36 hours after being discharged from the hospital, where he had been treated for COVID-19 pneumonia. He reported a sudden feeling of dyspnea and chest pain. The physical examination was unremarkable. No new changes were detected on the chest X-ray. D-dimer and cardiac-specific markers values were within the referent range. The patient underwent an urgent computerized tomography pulmonary angiography which revealed signs of bilateral arterial thrombosis. He was treated with a therapeutic dose of low molecular weight heparin and discharged after 15 days, with a recommendation to use a direct oral anticoagulant. CONCLUSIONS: Healthcare professionals should be aware that PE can occur as a late complication of COVID-19. Clinical suspicion of PE should lead physicians to use additional diagnostic methods to confirm or rule out PE, even if D-dimer levels are within the referent range. © 2021 Verduci Editore s.r.l. All rights reserved. | en |
dc.language.iso | en | en |
dc.source | European Review for Medical and Pharmacological Sciences | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123227794&doi=10.26355%2feurrev_202112_27647&partnerID=40&md5=6e5ebfa0e4d0a9d50dd90eb19d3b6613 | |
dc.subject | acetylsalicylic acid | en |
dc.subject | antibiotic agent | en |
dc.subject | apixaban | en |
dc.subject | corticosteroid | en |
dc.subject | D dimer | en |
dc.subject | low molecular weight heparin | en |
dc.subject | nadroparin | en |
dc.subject | prednisolone | en |
dc.subject | vitamin | en |
dc.subject | fibrin degradation product | en |
dc.subject | fibrin fragment D | en |
dc.subject | low molecular weight heparin | en |
dc.subject | adult | en |
dc.subject | case report | en |
dc.subject | clinical article | en |
dc.subject | computed tomography pulmonary angiography | en |
dc.subject | coronavirus disease 2019 | en |
dc.subject | dyspnea | en |
dc.subject | ground glass opacity | en |
dc.subject | heart right bundle branch block | en |
dc.subject | hospital readmission | en |
dc.subject | human | en |
dc.subject | lung embolism | en |
dc.subject | male | en |
dc.subject | oxygen therapy | en |
dc.subject | respiratory failure | en |
dc.subject | Review | en |
dc.subject | T wave | en |
dc.subject | thorax pain | en |
dc.subject | thorax radiography | en |
dc.subject | blood | en |
dc.subject | complication | en |
dc.subject | computed tomographic angiography | en |
dc.subject | diagnostic imaging | en |
dc.subject | immunology | en |
dc.subject | incidence | en |
dc.subject | isolation and purification | en |
dc.subject | lung | en |
dc.subject | lung embolism | en |
dc.subject | reference value | en |
dc.subject | thorax pain | en |
dc.subject | treatment outcome | en |
dc.subject | vascularization | en |
dc.subject | virology | en |
dc.subject | Adult | en |
dc.subject | Chest Pain | en |
dc.subject | Computed Tomography Angiography | en |
dc.subject | COVID-19 | en |
dc.subject | Fibrin Fibrinogen Degradation Products | en |
dc.subject | Heparin, Low-Molecular-Weight | en |
dc.subject | Humans | en |
dc.subject | Incidence | en |
dc.subject | Lung | en |
dc.subject | Male | en |
dc.subject | Pulmonary Embolism | en |
dc.subject | Reference Values | en |
dc.subject | SARS-CoV-2 | en |
dc.subject | Treatment Outcome | en |
dc.subject | Verduci Editore s.r.l | en |
dc.title | COVID-19 associated pulmonary embolism with D-dimer values within the referent range: A case report and review of the literature | en |
dc.type | other | en |